Novel dry powder preparations of whole inactivated influenza virus for nasal vaccination.

AAPS PharmSciTech
Robert J GarmiseAnthony J Hickey

Abstract

The purpose of these studies was to enhance mucosal and systemic antibody production in response to increased local residence time of a whole inactivated influenza virus administered as a dry powder nasal vaccine formulation. Spray-freeze-drying (SFD) particles suitable for nasal delivery were characterized for physico-chemical properties and stability. Mucoadhesive compounds (MA) were characterized for their effects on nasal residence time of vaccine powders in rats compared with published in vitro data and elicited immune responses. SFD particles (D(50) = 26.9 microm) were spherical with a specific surface area of 1.25 m(2)/g. Thermal analysis indicated SFD powders were amorphous and demonstrated improved stability with respect to liquid formulations under various storage conditions. In vitro physico-chemical studies and in vivo scintigraphic imaging experiments indicated sodium alginate (SA) and carboxymethylcellulose-high molecular weight (CMC-HMW) powder formulations most significantly increased residence time in Brown Norway rats. Intramuscular delivery provided equivalent serum antibody titers to intranasal (IN) powder without MA, in the presence of CMC-HMW, SA, and hydroxypropyl methylcellulose (HPMC-HMW) after initial ...Continue Reading

References

Feb 1, 1993·Journal of Pharmaceutical Sciences·K S Murthy, I Ghebre-Sellassie
Aug 1, 1997·Pharmaceutical Research·J F CarpenterT W Randolph
Apr 1, 1999·Pharmaceutical Research·Y F MaaC C Hsu
Apr 17, 1999·International Journal of Pharmaceutics·R J SoaneL Illum
Feb 9, 2000·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·M I UgwokeR Kinget
Aug 5, 2000·Journal of Controlled Release : Official Journal of the Controlled Release Society·M I UgwokeG Bormans
Feb 24, 2001·Pharmaceutical Research·H R CostantinoM A Tracy
Feb 24, 2001·The Journal of Pharmacy and Pharmacology·K G CarrasquilloK Griebenow
Mar 21, 2001·Vaccine·C LiCalsiC Witham
Apr 9, 2001·International Journal of Pharmaceutics·R J SoaneL Illum
Aug 23, 2001·Advanced Drug Delivery Reviews·L IllumS S Davis
Oct 2, 2001·Journal of Controlled Release : Official Journal of the Controlled Release Society·K G CarrasquilloK Griebenow
Feb 9, 2002·Journal of Pharmaceutical Sciences·Henry R CostantinoMark A Tracy
Aug 5, 2004·Pharmaceutical Research·Rahul SuranaRaj Suryanarayanan
Dec 9, 2004·Journal of Medical Microbiology·Michelle NelsonRichard W Titball
Jun 23, 2005·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·Yu-Hui ChengPeter Watts
Sep 29, 2005·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·Zhongshui YuRobert O Williams
Apr 6, 2006·AAPS PharmSciTech·Robert J GarmiseAnthony J Hickey
Mar 1, 2006·AAPS PharmSciTech·Robert J GarmiseAnthony J Hickey

❮ Previous
Next ❯

Citations

Aug 30, 2011·Langmuir : the ACS Journal of Surfaces and Colloids·Jiun-Jeng ChenAnthony B Brennan
Mar 22, 2013·AAPS PharmSciTech·Ragwa M FaridAbd El Azeem R Ebian
Nov 26, 2009·Journal of Drug Targeting·Mohsen Tafaghodi, Somayeh Rastegar
Sep 10, 2011·Journal of Pharmaceutical Sciences·Sheena H WangAnthony J Hickey
May 9, 2012·European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Für Pharmazeutische Verfahrenstechnik E.V·Andreas Bernkop-Schnürch, Sarah Dünnhaupt
Oct 5, 2010·The Lancet Infectious Diseases·Jean-Pierre AmorijAnke Huckriede
Mar 12, 2010·Journal of Controlled Release : Official Journal of the Controlled Release Society·V SalujaW L J Hinrichs
Feb 27, 2010·Journal of Controlled Release : Official Journal of the Controlled Release Society·Kohta MohriHirokazu Okamoto
Oct 15, 2014·Advanced Drug Delivery Reviews·José L TlaxcaRichard L Remmele
Sep 11, 2012·International Journal of Pharmaceutics·Sören N EggerstedtAlf Lamprecht
Feb 11, 2012·International Journal of Pharmaceutics·Suzanne M D'AddioHak-Kim Chan
May 9, 2015·Artificial Cells, Nanomedicine, and Biotechnology·Abdul AhadMohd Mujeeb
Feb 25, 2015·Artificial Cells, Nanomedicine, and Biotechnology·Abdul AhadMohd Mujeeb
Feb 6, 2013·Pharmaceutical Development and Technology·Can ÇokçalışkanSevda Şenel
Apr 23, 2015·International Journal of Pharmaceutics·Stefan WanningAlf Lamprecht
May 1, 2016·International Journal of Pharmaceutics·Daniel A LeClairMichael R Thompson
Oct 21, 2016·AAPS PharmSciTech·Stefan WanningAlf Lamprecht
Sep 20, 2017·Human Vaccines & Immunotherapeutics·Gaurav KanojiaGideon Kersten
Jun 23, 2009·Expert Review of Vaccines·H Ciğdem ArcaSevda Senel
Dec 22, 2015·Journal of Parasitic Diseases : Official Organ of the Indian Society for Parasitology·Irfan-Ur-Rauf TakFayaz Ahmad
Aug 4, 2019·Pharmaceutics·Marie Hellfritzsch, Regina Scherließ
Dec 25, 2019·Pharmaceutical Research·Dominique N PricePavan Muttil
Jan 4, 2020·Neurotherapeutics : the Journal of the American Society for Experimental NeuroTherapeutics·Bhavani KashyapWilliam H Frey Ii
Nov 28, 2012·Expert Review of Vaccines·David McAdamsDebra Kristensen
Aug 22, 2018·Pharmaceutics·Fakhrossadat EmamiDong Hee Na
Jan 1, 2014·International Scholarly Research Notices·Upendra NagaichJaya Nagaich
Jun 22, 2010·Expert Opinion on Drug Delivery·Barbara LuppiVittorio Zecchi
Mar 24, 2018·Journal of Drug Delivery·Piyush Mehta
Jan 24, 2021·Advanced Drug Delivery Reviews·Kendall B Preston, Theodore W Randolph
Apr 10, 2021·Applied Microbiology and Biotechnology·Ravinder Kumar, Bhushan N Kharbikar
Apr 10, 2021·AAPS PharmSciTech·Khaled AboulFotouhRobert O Williams
Oct 20, 2018·Journal of Controlled Release : Official Journal of the Controlled Release Society·Sachin G ThakkarZhengrong Cui
Jul 3, 2021·Pharmaceutics·Tuğrul Mert SerimAlf Lamprecht

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.